HRS 2018 Insights: Read about future technologies and how T3 Labs can be your partner in emerging EP research.

As the leading annual electrophysiology event, HRS will always bring the latest advancements in pacing, ablation and mapping to the society’s annual meeting. The 2018 edition was no exception and included a few variations on atrial fibrillation (AF) ablations. Catheter Ablation vs/ Antiarrhythmic Drug Therapy The big news from the show was the dissemination of…

Is one young Georgia Tech company about to end complications from epidural misplacement? Read about their experience at T3 Labs.

“It is exceedingly rare for student medtech projects to become companies,” Rains said. “But in a very intentional way, and thanks to a robust local and regional medtech ecosystem, that is exactly what is happening here.” Among the approximately 4 million births in the United States each year, 2.4 million of those mothers elect to…

Selecting the right preclinical partner: Why Cell Constructs utilizes T3 Labs as their trusted Preclinical CRO

For medical product innovators large and small, T3 Labs prides itself on delivering the highest value preclinical testing and bioskills training services available. Depending on the class and type of submission, not every medical product requires preclinical studies, however, completing preclinical studies is advantageous for proof of concept, when raising capital, applying for reimbursement, and…

Talking Good Lab Practices(GLP) with FDA Representatives and Industry Leaders at SQA 2017

The Society of Quality Assurance is dedicated to promoting quality in the regulated research community, including clinical settings, laboratories, and manufacturing facilities. This year the annual meeting, held March 26-31, boasted attendance of over 800. Located in National Harbor, Maryland, the conference was in close proximity to Washington DC, posing a unique opportunity for more…

Meeting the top needs in preclinical studies for orthopedic devices: the first structural, completely porous bioactive glass

For medical product innovators large and small, T3 Labs prides itself on delivering the highest value preclinical testing and bioskills training services available. Once Bio2 Technologies reached the second stage in the process from concept to cure to commercialization – preclinical – they entrusted T3 Labs to deliver three consecutive studies for the first completely…

Meeting the top needs in preclinical cardiology. Understanding the interaction of next generation bioresorbable platforms with underlying vascular tissue.

How T3 Labs helped Abbott Vascular, Dr. Bill Gogas, Dr. Sandeep Kumar, the core teams of Emory University lead by Dr. Habib Samady, and Georgia Tech lead by Dr. Hanjoong Jo, generate and utilize observations from a very long-term translational study toward the understanding of very late vasomotor responses and gene expression profiles in arteries…

From the back of the napkin through preclinical and commercialization for cardiology interventions

T3 Labs and GCMI always stand ready to help new medical devices and their innovators advance from ‘back of the napkin’ ideas often generated in clinical practice from concept to commercialization and eventually, to cure. Recently T3 Labs’ Deepal Panchal joined Health Connect South Radio Host CW Hall and Dr. Neil Weintraub, MD, Kupperman Eminent…